Gene · 665
Papers2,878
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,878
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers. | Aging (Albany NY) | 2023 | 37253634 | PubTator, text mining | PubMed |
| The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy. | Acta Pharm Sin B | 2023 | 37250161 | PubTator, text mining | PubMed |
| Polygalacin D inhibits the growth of hepatocellular carcinoma cells through BNIP3L-mediated mitophagy and endogenous apoptosis pathways. | Chin J Nat Med | 2023 | 37245873 | PubTator, text mining | PubMed |
| p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act. | Nutrients | 2023 | 37242146 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies. | Biomedicines | 2023 | 37239170 | PubTator, text mining | PubMed |
| Tunable Method for the Preparation of Layered Double Hydroxide Nanoparticles and Mesoporous Mixed Metal Oxide Electrocatalysts for the Oxygen Evolution Reaction. | Langmuir | 2023 | 37236238 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease. | Front Pharmacol | 2023 | 37234707 | PubTator, text mining | PubMed |
| Machine learning-based glycolysis-associated molecular classification reveals differences in prognosis, TME, and immunotherapy for colorectal cancer patients. | Front Immunol | 2023 | 37228620 | PubTator, text mining | PubMed |
Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes. | Front Endocrinol (Lausanne) | 2023 | 37223030 | PubTator, text mining | PubMed |
| Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor. | Aging Cell | 2023 | 37222020 | PubTator, text mining | PubMed |
| Cancer cachexia: molecular mechanisms and treatment strategies. | J Hematol Oncol | 2023 | 37217930 | PubTator, text mining | PubMed |
| A Lipid Perspective on Regulated Pyroptosis. | Int J Biol Sci | 2023 | 37215994 | PubTator, text mining | PubMed |
| Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment. | Cell Commun Signal | 2023 | 37208730 | PubTator, text mining | PubMed |
| Mitochondrial Dynamics during Development. | Newborn (Clarksville) | 2023 | 37206581 | PubTator, text mining | PubMed |
| Mitophagy associated self-degradation of phosphorylated MAP4 guarantees the migration and proliferation responses of keratinocytes to hypoxia. | Cell Death Discov | 2023 | 37198170 | PubTator, text mining | PubMed |
| The mitochondrial intermembrane space protein mitofissin drives mitochondrial fission required for mitophagy. | Mol Cell | 2023 | 37192628 | PubTator, text mining | PubMed |
| Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators. | Aging Dis | 2023 | 37191431 | PubTator, text mining | PubMed |
| Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer. | Cancers (Basel) | 2023 | 37190124 | PubTator, text mining | PubMed |
| Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. | Biomedicines | 2023 | 37189787 | PubTator, text mining | PubMed |
| β Cell and Autophagy: What Do We Know? | Biomolecules | 2023 | 37189396 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/665/papers?page=22